CS Diagnostics Corp. (CSDX)
OTCMKTS · Delayed Price · Currency is USD
0.0110
+0.0049 (80.33%)
At close: Nov 3, 2026
CS Diagnostics Revenue
In the year 2025, CS Diagnostics had annual revenue of $204.00K with 83.93% growth. CS Diagnostics had revenue of $109.80K in the quarter ending December 31, 2025, with 2,323.84% growth. That makes CS Diagnostics the 45,492nd largest company in the world by revenue and 6,623rd in the United States.
Revenue
204.00K
Revenue Growth
+83.93%
P/S Ratio
13.48
Revenue / Employee
204.00K
Employees
1
Market Cap
2.75M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 204.00K | 93.09K | 83.93% |
| Dec 31, 2024 | 110.91K | -15.13K | -12.00% |
| Dec 31, 2023 | 126.04K | - | - |
| Dec 31, 2009 | - | - | - |
| Dec 31, 2008 | - | - | - |
| Dec 31, 2007 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2006 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2005 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2004 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2003 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Fuse Medical | 18.40M |
| QHSLab | 3.02M |
| Kelyniam Global | 2.67M |
| Vycor Medical | 1.81M |
| Tian'an Technology Group | 697.48K |
| CYduct Diagnostics | 344.78K |
| AI Maverick Intel | 92.26K |
| REMSleep Holdings | 11.90K |
CS Diagnostics News
- 3 months ago - 5 microcap software stocks expected to soar by triple digits as the companies' sales pop - Market Watch
- 1 year ago - CS Interpharm and CS Diagnostics Pharma Complete Conversion of Preferred Shares to Common Stock, Strengthening CSDX's Path to Consolidated Financial Reporting - Accesswire
- 1 year ago - CS Diagnostics Corp. Launches Regulation D, Rule 506(c) Investment Offering - Accesswire
- 1 year ago - CS Diagnostics Corp. (OTCQB: CSDX) Accelerates Global Expansion with Key Regulatory Milestones and Record Growth - Accesswire
- 1 year ago - CS Diagnostics Corp. Submits Patent Application For CS-Protect Hydrogel in the US Market - Accesswire
- 1 year ago - CS Diagnostics Corp. Submitted Final Form-10 Registration Statement Draft to the processing team for preparation of Edgardization and filing with the U.S. Securities and Exchange Commission ("SEC") - Accesswire
- 1 year ago - CS Diagnostics Corp. to Present at the Small Cap Growth Virtual Investor Conference June 26th - GlobeNewsWire
- 1 year ago - CS Diagnostics Corp. CSDX to Present at the Small Cap Growth Virtual Investor Conference on June 26, 2025 at 12:30pm EDT - Accesswire